Ginkgo Bioworks Holdings (MEX:DNA) Moat Score: 5/10 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:DNA Ginkgo Bioworks Holdings Inc MEX:DNA
54 GF Score
Price MXN170.00
GF Value MXN149.41
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Moat Score?

Ginkgo Bioworks Holdings MEX:DNA 54 Moat Score is 5 as of Aug. 02, 2026. GuruFocus rates MEX:DNA with a GF Score™ of 54/100 and a GF Value™ of MXN149.41 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,394 Biotechnology companies, Ginkgo Bioworks Holdings ranks better than 96.7% on this metric.

Ginkgo Bioworks Holdings has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Ginkgo Bioworks Holdings has Narrow Moat: Ginkgo Bioworks Holdings Inc has a solid narrow moat due to its valuable intellectual property and strong R&D capabilities. However, it faces competition in the synthetic biology space, limiting its market leadership and pricing power.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Ginkgo Bioworks Holdings might have Narrow Moat - Solid narrow moat.

Ginkgo Bioworks Holdings  (MEX:DNA) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Ginkgo Bioworks Holdings Moat Score Related Terms

MEX:DNA vs RZLT, EIKN, ARTV: Moat Score Comparison

For the Biotechnology subindustry, Ginkgo Bioworks Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ginkgo Bioworks Holdings Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ginkgo Bioworks Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where Ginkgo Bioworks Holdings's Moat Score falls into.


MEX:DNA
54GF Score
Ginkgo Bioworks Holdings Inc MEX:DNA
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Ginkgo Bioworks Holdings (MEX:DNA) has a Moat Score of 5 as of Aug. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Ginkgo Bioworks Holdings ranks #46 out of 1394 companies in the Biotechnology industry, placing it in the top 3.3%.
Is Ginkgo Bioworks Holdings' Moat Score too high?
Ginkgo Bioworks Holdings' current Moat Score is 5. The Biotechnology industry median Moat Score is 2.00. Ginkgo Bioworks Holdings' value of 5 is 150% above this industry median. Based on the distribution chart, Ginkgo Bioworks Holdings ranks #46 out of 1394 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Moat Score compare to RZLT and EIKN?
According to the Biotechnology industry distribution chart, Ginkgo Bioworks Holdings ranks #46 out of 1394 companies for Moat Score. This places Ginkgo Bioworks Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Ginkgo Bioworks Holdings' value of 5 is 150% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,394 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ginkgo Bioworks Holdings's current Moat Score of 5 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginkgo Bioworks Holdings's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ginkgo Bioworks Holdings (MEX:DNA) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN149.41, compared to a current price of MXN170.00 — trading 13.8% above its estimated fair value. The current Moat Score is 5 and 150% above the Biotechnology industry median of 2.00. Ginkgo Bioworks Holdings' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (MEX:DNA), the current Moat Score is 5 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ginkgo Bioworks Holdings (MEX:DNA) Overvalued in 2026?

Based on GuruFocus' analysis, Ginkgo Bioworks Holdings stock appears to be overvalued. The current stock price of MXN170.00 is trading 13.8% above its estimated GF Value™ of MXN149.41. GuruFocus considers Ginkgo Bioworks Holdings to be Modestly Undervalued.

Key valuation signals for MEX:DNA:

  • Moat Score: 5
  • GF Value™: MXN149.41 vs. price of MXN170.00 (13.8% above fair value)
  • GF Score™: 54/100 with 5 warning signs
  • Industry Position: 150% above the Biotechnology median (#46 of 1394)

No single metric tells the full story. See the MEX:DNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USA
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
54GF Score

Get the complete analysis for MEX:DNA

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN170.00
Price
MXN149.41
GF Value